NEJM This Week — March 24, 2022

Featuring articles on a single-dose liposomal amphotericin B treatment for cryptococcal meningitis, hydrocortisone to prevent bronchopulmonary dysplasia, darolutamide in metastatic prostate cancer, trastuzumab deruxtecan for HER2-positive breast cancer, addressing vaccine inequity, and targeting gene therapy to muscle; a review article on managing glycemia in children with type 1 diabetes; a case report of a woman with fever, myalgias, diarrhea, and cough; and Perspective articles on digital inclusion as health care, on a new way to contain unaffordable medication costs, and on an NPO.